Evolus (EOLS) Equity Ratio (2017 - 2026)

Evolus (EOLS) reported Equity Ratio of 0.13 for Q1 2026, down 321.42% on a YoY basis from 0.06 in Q1 2025, and down 27.51% quarter-over-quarter from 0.1 in Q4 2025.

Evolus (EOLS) Equity Ratio (2017 - 2026) Analysis & Trends

Evolus has reported Equity Ratio for 10 years, with the latest figure at 0.13 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio fell 321.42% year-over-year to 0.13; the trailing twelve-month figure through Mar 2026 stood at 0.13 (down 321.42% YoY), and the FY2025 full-year result was 0.1, down 530.85% from the prior year.
  • Equity Ratio for Q1 2026 stood at 0.13, down from 0.1 in the prior quarter.
  • The five-year high for Equity Ratio was 0.3 in Q1 2022, with the low at 0.13 in Q3 2025.
  • Historically, Equity Ratio has averaged 0.02 across 5 years, with a median of 0.02 in 2024.
  • Annual changes were most pronounced in 2024 — Equity Ratio surged 300.51% — and 2025, when it plunged 611.94%.
  • Evolus' Equity Ratio stood at 0.1 in 2022, then tumbled by 205.32% to 0.11 in 2023, then soared by 121.69% to 0.02 in 2024, then sank by 530.85% to 0.1 in 2025, then decreased by 27.51% to 0.13 in 2026.
  • The last three Equity Ratio figures came in at 0.13 (Q1 2026), 0.1 (Q4 2025), and 0.13 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 0.21
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 0.21
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 0.88
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 0.73
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 0.69
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 0.49
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 0.41
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 0.52
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 0.20
10 Evolus 435.45 Mn 385.65 Mn 48.90 Mn -0.13

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.13
Dec 31, 2025 -0.10
Sep 30, 2025 -0.13
Jun 30, 2025 -0.08
Mar 31, 2025 -0.03
Dec 31, 2024 0.02
Sep 30, 2024 0.03
Jun 30, 2024 0.08
Mar 31, 2024 0.08
Dec 31, 2023 -0.11
Sep 30, 2023 -0.12
Jun 30, 2023 -0.04
Mar 31, 2023 0.04
Dec 31, 2022 0.10
Sep 30, 2022 0.15
Jun 30, 2022 0.22
Mar 31, 2022 0.30
Dec 31, 2021 0.32
Sep 30, 2021 0.45
Jun 30, 2021 0.44